A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma
Abstract Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous or/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure. This necessitates the development of novel therapies and thus requires a model of advanced RB for testing candi...
Main Authors: | Duangporn Saengwimol, Duangnate Rojanaporn, Vijender Chaitankar, Pamorn Chittavanich, Rangsima Aroonroch, Tatpong Boontawon, Weerin Thammachote, Natini Jinawath, Suradej Hongeng, Rossukon Kaewkhaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-10-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-018-34037-y |
Similar Items
-
Retinoblastoma: Etiology, Modeling, and Treatment
by: Rossukon Kaewkhaw, et al.
Published: (2020-08-01) -
Therapeutic uses of topotecan for thoracic malignancies
by: Saoirse O. Dolly, et al.
Published: (2011-12-01) -
Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases
by: Cheng Y, et al.
Published: (2018-04-01) -
Adverse drug reaction after intravitreal injection of topotecan
by: Subina Narang, et al.
Published: (2020-01-01) -
Immediate Versus Delayed Topotecan after First-line Therapy in Small Cell Lung Cancer
by: Cong XUE, et al.
Published: (2010-03-01)